ロード中...
Serotonin-2B receptor antagonism increases the activity of dopamine and glutamate neurons in the presence of selective serotonin reuptake inhibition
Previous research has implicated the serotonin-2B (5-HT(2B)) receptor as a possible contributor to the antidepressant-like response. Aripiprazole has been successfully used in combination with selective serotonin reuptake inhibitors (SSRIs) in treatment-resistant depression and it, among all recepto...
保存先:
| 出版年: | Neuropsychopharmacology |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547697/ https://ncbi.nlm.nih.gov/pubmed/32473594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41386-020-0723-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|